UnitedHealth Group has struggled with poor performance and controversy this year. Eli Lilly has excelled in the obesity drug market. Stock valuations provide essential context for buying decisions. UnitedHealth Group and Eli Lilly are healthcare giants with opposite 2025 trajectories. UHG has faced challenges and investigations, while Eli Lilly has seen significant growth.

Read more at Yahoo Finance: UnitedHealth Group or Eli Lilly?